Leading life science executives, government officials, academic leaders, and investors gather for two day off-the-record ...

Simris Group's Q1 2025 report released today, highlights a period of significant focus on advancing their ADC payload ...

Heidelberg Pharma to Present Promising New Clinical Data on its Lead ATAC Candidate HDP-101 at EHA 2025HDP-101 demonstrated complete response in one female patient from cohort 5R&D Webinar to be ...

CNX Therapeutics to accelerate European growth strategy with Inflexion's £2.3bn Continuation FundLondon, May 15th, 2025 – CNX Therapeutics Limited (“CNX Therapeutics”), a European specialty ...

LEO Pharma delivers 9% revenue growth at constant exchange rates and doubles adjusted EBITDA margin to 16% Ballerup, Denmark, 15 May, 2025 - In Q1, LEO Pharma continued its robust growth, driven by ...

Leading life sciences technology company to accelerate adoption of automated procurement and supplier diversity worldwideBOSTON and LONDON , May 15, 2025 (GLOBE NEWSWIRE) -- Tariffs, trade barriers, ...

Market is undergoing a transformative phase, driven by the increasing demand for precision medicine and targeted therapies.

EBITDA before special items decreases to 4.085 billion euros (minus 7.4 percent) / Moderate decline in sales (Fx & p adj.) at ...

IntroductionThe global in vitro fertilization market has entered a phase of consistent and transformational growth driven by ...

IntroductionThe global vaccines market has witnessed unprecedented growth in recent years, driven by technological ...

Overview of the Bone Marrow Transplantation MarketBone marrow transplantation market, also referred to as hematopoietic stem ...

Market OverviewThe electronic health records market encompasses software solutions used to collect, store, and manage patient ...